All In Biotech

Drug Trial Radar · NCT00690833

Efficacy of Desonide (Desonatetm) Gel 0.05% in Younger and Older Subjects With Atopic Dermatitis

Last checked: Nov 19, 2026Latest source record: Sep 10, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

41

Actual

Start

Aug 2007

Primary completion

Dec 2007

Study completion Nov 2009

Sponsor

Lead sponsor
Wake Forest UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jun 5, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 3 months
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this research study is to better understand how this study drug works when people use it to treat atopic dermatitis. Desonate has been approved by the US Food and Drug Administration (FDA) for atopic dermatitis.

Conditions

  • Atopic Dermatitis

Interventions

  • topical desonide hydrogel 0.05%Drug

    apply the smallest amount of study medication possible that is just sufficient to cover all lesions of the standard cortisone-type medication twice daily (morning and evening) for up to 4 weeks to all of their AD lesions

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Investigator Global Assessment at Week 4Time frame: Week 4

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Wake Forest University Health Sciences Dermatology

    Winston-Salem, North Carolina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.